#ThinkSabio Latest News
$ALT top-line data from Phase 2b IMPACT trial of pemvidutide in MASH to be reported in Q2 Cash, cash equivalents $132M
$ALT top-line data from Phase 2b IMPACT trial of pemvidutide in MASH to be reported in Q2 Cash, cash equivalents $132M
